Eligibility Module
The Eligibility Module contains detailed information about who can participate in the clinical trial. This includes eligibility criteria, age restrictions, gender requirements, healthy volunteer status, and study population descriptions, helping researchers understand who is eligible to participate in the study.
Eligibility Module path is as follows:
Study -> Protocol Section -> Eligibility Module
Eligibility Module
Ignite Creation Date:
2025-12-25 @ 2:12 AM
Ignite Modification Date:
2025-12-25 @ 2:12 AM
NCT ID:
NCT03620760
Eligibility Criteria:
Inclusion Criteria:
* Patients admission for coronary artery disease treatment with non-emergency percutaneous intervention with stent deployment
* 18 years≤age≤80 years
* Patients understands the study requirements and the treatment procedures and provided informed consent before the procedure
Exclusion Criteria:
* Allergy or intolerance to ticagrelor or aspirin
* Need for oral anticoagulation therapy
* Concomitant oral or intravenous therapy with strong inhibitors of Cytochrome P450, family 3, subfamily A (CYP3A), Substrates of CYP3A with narrow therapeutic indices or strong inducers of CYP3A
* Active bleeding, previous history of intracranial hemorrhage, gastrointestinal hemorrhage in the past 6 months and major operation within 30 days
* High risk of bradyarrhythmias
* Severe liver dysfunction and abnormal renal function
* Patient is a woman who is pregnant or nursing
* Unable or unwilling to give written informed consent
Healthy Volunteers:
False
Sex:
ALL
Minimum Age:
18 Years
Maximum Age:
80 Years
Study:
NCT03620760
Study Brief:
Protocol Section:
NCT03620760